OLVIG
FLNA

Oliver Lagore Vanvalin Investment Group’s Filana Therapeutics FLNA Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,100
Closed -$32.4K – 725
2024
Q3 		$32.4K Buy
1,100
+75
+7% +$1.73K 0.01% 290
2024
Q2 		$12.7K Buy
+1,025
New +$21.6K ﹤0.01% 389

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's FLNA Position: Q4 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 1,100 shares — an estimated $32.4K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in FLNA in Q2 2024 and held it in 2 quarters. The position peaked at $32.4K in Q3 2024. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 1,100 Filana Therapeutics shares in Q4 2024, an estimated $32.4K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Filana Therapeutics in Q2 2024 and held it in 2 quarters.
  • Oliver Lagore Vanvalin Investment Group's Filana Therapeutics position peaked at $32.4K in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q4 2024, filed 1 Apr 2025.